Jeremys
Essential
- Joined
- 28.09.20
- Messages
- 75
- Reaction score
- 238
- Points
- 18
At first, the extortionists demanded $25 million from Pierre Fabre, but when the victim refused to pay, they doubled the amount.
One of the largest pharmaceutical groups in France, Pierre Fabre, has become a victim of the extortionate REvil software. At first, the attackers demanded a ransom of $25 million, but when the victim refused to pay, they doubled the amount.
Pierre Fabre is the second largest French pharmaceutical group and the second largest dermatology and cosmetology laboratory in the world. The company produces a wide range of pharmaceutical products, ranging from chemotherapeutic drugs to skin care products.
According to the company, the attack occurred on March 31, 2021, and within 24 hours it was isolated. However, in order to stop the spread of the threat, Pierre Fabre had to gradually and temporarily suspend most of the production processes.
"As a precautionary measure and in accordance with the risk management plan, the Group's information system was immediately put on standby to contain the spread of the virus. This has led to a gradual temporary shutdown of most production processes (with the exception of the production facility in Gaillac (in Tarn in France), which produces active ingredients for pharmaceutical and cosmetic products), " representatives of Pierre Fabre said.
One of the largest pharmaceutical groups in France, Pierre Fabre, has become a victim of the extortionate REvil software. At first, the attackers demanded a ransom of $25 million, but when the victim refused to pay, they doubled the amount.
Pierre Fabre is the second largest French pharmaceutical group and the second largest dermatology and cosmetology laboratory in the world. The company produces a wide range of pharmaceutical products, ranging from chemotherapeutic drugs to skin care products.
According to the company, the attack occurred on March 31, 2021, and within 24 hours it was isolated. However, in order to stop the spread of the threat, Pierre Fabre had to gradually and temporarily suspend most of the production processes.
"As a precautionary measure and in accordance with the risk management plan, the Group's information system was immediately put on standby to contain the spread of the virus. This has led to a gradual temporary shutdown of most production processes (with the exception of the production facility in Gaillac (in Tarn in France), which produces active ingredients for pharmaceutical and cosmetic products), " representatives of Pierre Fabre said.